scientific program - World Allergy Organization

More documents

Recommendations

Info

THURSDAY, 11 SEPTEMBER 56 WAO Congress–XVIII ICACI Final Program THURSDAY, 11 SEPTEMBER - continued Free Communication Session 15:45 - 17:15 FC16 - Allergens: Clinical Implications Waterfront Ballroom B, Fairmont Waterfront Hotel CME Credit: 1.5 Co-Chair: Kamal Hanna, Egypt Co-Chair: Rudolf Valenta, Austria Abstract #O-16-1 Incidence of IgE against Ascaris lumbricoides and Toxocara canis in patients with very high IgE, and with abdominal discomfort, eczema or wheezing Nordling K 1 , Whist JE 2 , Skaar OH 3 1 Sykehuset Innlandet Health Authority, Gjovik, Oppland, Norway, 2 Sykehuset Ostfold Health Authority, Fredrikstad, Ostfold, Norway, 3 DPC Scandinavia, Drammen, Buskerud, Norway Abstract #O-16-2 Trichophyton rubrum, an important fungal allergen in the pathogenesis of nasal polyposis and sinusitis Hao J 1 , Shang HS 1 , Pang YT 1 , Bi XZ 1 , Chew FT 1 , Wang D 1 1 National University of Singapore, Singapore, Singapore Abstract #O-16-3 Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica pollen members of Urticaceae Sharma S 1 , Panzani R 2 , shah A 3 , Kumar P 4 , Singh AB 5 1 Institute of Genomics and Integrative Biology, Delhi, India, 2 Laboratoire de Recherches, Marseilles, France, 3 V. P. Chest Institute, Delhi, India, 4 Institute of Genomics and Integrative Biology, Delhi, India, 5 Institute of genomics and Integrative Biology, Delhi, India Abstract #O-16-4 Common aeroallergens and the role of hyposensitization in allergic rhinitis and its comorbidities Sharma S 1 1 Dr Sanjiv’s E.N.T. Care & Allergy Centre, Jalandhar, Punjab, India Abstract #O-16-5 Allergenicity of homologs to fungal, pollen, food and insect allergens in dust mite, Blomia tropicalis: identification of new classes of panallergens Shang HS 1 , Kuay KT 1 , Wang WL 1 , Lim SH 1 , Chew FT 1 1 National University of Singapore, Singapore, Singapore Abstract #O-16-6 The importance of knowing the actual pollination season for common allergenic trees Coates LL 1 , Coates FC 1 , Yang WH 2 1 Aerobiology Research Laboratories, Ottawa, Ontario, Canada, 2 Allergy and Asthma Research Centre, Ottawa, Ontario, Canada Presenting authors indicated in bold. SCIENTIFIC PROGRAM Free Communication Session 15:45 - 17:15 FC17 - Asthma Therapy II Waterfront Ballroom C, Fairmont Waterfront Hotel CME Credit: 1.5 Co-Chair: Motohiro Kurosawa, Japan Co-Chair: Richard Nicklas, United States Abstract #O-17-1 Ciclesonide, a novel inhaled corticosteroid (ICS), does not suppress hypothalamic-pituitary-adrenal (HPA)-axis function Kaliner M 1 , White M 1 , Chervinsky P 2 , Amin D 3 , Rohatagi S 3 , Williams J 3 , Kundu S 3 , Banerji D 3 , Hamedani P 3 1 Institute for Allergy and Asthma, Wheaton, MD, USA, 2 New England Clinical Studies, North Dartmouth, MA, USA, 3 Aventis, Bridgewater, NJ, USA Abstract #O-17-2 Novel immunomodulatory oligonucleotides (IMOs) prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma Agrawal DK 1 , Edwan J 1 , Kandimalla ER 2 , Yu D 2 , Agrawal S 2 1 Creighton University School of Medicine, Omaha, NE, USA, 2 Hybridon Inc., Cambridge, MA, USA Abstract #O-17-3 Omalizumab, an anti-IgE antibody, suppresses airway inflammation in mild allergic asthma via a reduction in mast cell surface-associated interleukin-4 Djukanovic R 1 , Wilson SJ 1 , Kraft M 2 , Jarjour N 3 , Steel M 1 , Chung KF 4 , Bau W 5 , Fowler-Taylor A 5 , Matthews J 5 , Busse WW 5 , Holgate ST 5 , Fahy J 5 1 University of Southampton, Southampton, UK, 2 National Jewish Center, Denver, USA, 3 University of Wisconsin, Madison, USA, 4 National Heart and Lung Institute, Imperial College, London, UK, 5 East Hanover, USA Abstract #O-17-4 Omalizumab, an anti-IgE antibody, decreases the rate of asthma deterioration-related incidents in patients with poorly controlled allergic asthma Chung KF 1 , Britton M 2 , Harnest U 3 , Ayre G 4 , Blogg M 4 , Fox H 4 1 National Heart and Lung Institute, Imperial College, London, UK, 2 St Peters Hospital, Chertsey, UK, 3 CLIN-GUARD GMBH, Munich, Germany, 4 Novartis Horsham Research Centre, Horsham, UK Abstract #O-3-3 De novo synthesis of an antagonistic natriuretic peptide in the lung attenuates allergic asthma in mice Mohapatra S 1 , Lockey RF 1 , Hellerman G 1 , Kong X 1 , San Juan H 1 , Zhang W 1 , Gonnarsdottir J 1 1 University of South Florida College of Medicine & VA Hospital, Tampa, FL, USA Abstract #O-17-6 The effect of swimming training on aerobic capacity and pulmonary functions in children with asthma Altintas D 1 , Cevit O 1 , Ergen N 2 , Karakoc G 1 , Inci D 1 1 Cukurova University, Faculty of Medicine, Pediatric Allergy- Immunology, Adana, Turkey, 2 Cukurova University, Faculty of Medicine, Physiology Department, Adana, Turkey
Presenting authors indicated in bold. WAO Congress–XVIII ICACI Final Program SCIENTIFIC PROGRAM THURSDAY, 11 SEPTEMBER - continued Free Communication Session 15:45 - 17:15 FC18 -Drug Allergy Room 12, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Co-Chair: Juan Ivancevich, Argentina Co-Chair: Robert Schellenberg, Canada Abstract #O-18-1 Clinical and biochemical differences in nasal and pulmonary hypersensitivity responses to aspirin Swierczynska M 1 , Nizankowska E 1 , Radwan J 1 , Nagraba K 1 , Gielicz A 1 , Szczeklik A 1 1 Dept. of Medicine CMUJ, Cracow, Poland Abstract #O-18-2 Celecoxib is well tolerated in patients with NSAID intolerance Elshorst-Schmidt T 1 , Kleinhans M 1 , Koeberich V 1 , Kaufmann R 1 , Boehncke WH 1 1 Dept. of Dermatology, Univ. of Frankfurt, Frankfurt, Germany Abstract #O-18-3 Excessive medication adverse events in women with chronic fatigue syndrome (CFS) Baraniuk JN 1 , Maibach H 1 1 Georgetown University, Washington, DC, USA Abstract #O-18-4 Tolerance to fondaparinux in a patient allergic to heparins and heparinoids Ludwig RJ 1 , Beier C 1 , Lindhoff-Last E 2 , Kaufmann R 1 , Boehncke WH 1 1 Dept. of Dermatology, Univ. of Frankfurt, Frankfurt, Germany, 2 Dept. of Internal Medicine, Univ. of Frankfurt, Frankfurt, Germany Abstract #O-18-5 A novel, time-efficient clinical practice pathway reduces prophylactic vancomycin use in surgical patients with history of penicillin allergy Madaan A 1 , Markus P 1 , Li JT 1 1 Mayo Clinic, Rochester, MN, USA Abstract #O-18-6 Allergic reaction to cephalosporins and their cross-reactivity with penicillins in children Atanaskovic-Markovic M 1 , Vuckovic O 2 , Todoric D 3 , Nestorovic B 1 1 University Children’s Hospital, Beograd, Yugoslavia, 2 Institute for Immunology and Virusology, Torlak, Beograd, Yugoslavia, 3 Primary Care DZ, Beograd, Yugoslavia Free Communication Session 15:45 - 17:15 FC19 -Food Allergy Room 11, Vancouver Convention & Exhibition Centre CME Credit: 1.5 Co-Chair: John Dean, Canada Co-Chair: Wade Watson, Canada Abstract #P-19-7 CD86 regulates peanut-specific cytokine responses in non-allergic humans Thottingal T 1 , Simons FER 1 , Stanley S 2 , Bannon GA 2 , HayGlass KT 1 1 University of Manitoba, Winnipeg, Manitoba, Canada, 2 University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA Abstract #O-19-2 Prognostic factors of cow’s milk allergy presenting with gastrointestinal symptoms in early infancy Suzuki S 1 , Shimojo N 1 , Hoshioka A 1 , Numata T 1 , Tomiita M 1 , Kohno Y 1 , Arima T 1 , Tateno N 1 , Kojima H 1 1 Graduate School of Medicine, Chiba University, Chiba, Chiba, Japan Abstract #O-19-3 Evaluation of food challenge tests in terms of clinical applications Shinoda S 1 , Inoue R 2 , Teramoto T 2 , Kondo N 2 1 Gujo Central Hospital, Gifu University, School of Medicine, Gujo, Japan, 2 Gifu University, School of Medicine, Department of Pediatrics, Gifu, Japan Abstract #O-19-4 The Norwegian national reporting system and register of severe allergic reactions to food Lovik M 1 , Wiker HG 1 , Kjelkevik R 2 , Egaas E 3 , Stensby BA 1 , Gondrosen B 2 1 Norwegian Institute of Public Health, Oslo, Norway, 2 Norwegian Food Control Authority, Oslo, Norway, 3 Veterinary Institute, Oslo, Norway 57 Abstract #O-19-5 The U.S. Food and Drug Administration: approaches to food allergens Vierk KA 1 1 U.S. Food and Drug Administration, College Park, MD, USA Abstract #O-19-6 Prevalence and severity of oral allergy syndrome Zauli D1 , Zucchini S1 , Grassi A1 , Vukatana G1 , Ballardini G1 , Bianchi FB1 1Dept. Int Med, Cardioangiol, Hepatol, University of Bologna, Bologna, Italy THURSDAY, 11 SEPTEMBER
Page 1:
FINAL PROGRAM World Allergy Organiz
Page 4 and 5:
2 WAO Congress-XVIII ICACI Final Pr
Page 6 and 7:
4 World Allergy Organization (WAO)-
Page 8 and 9: 6 WAO Congress-XVIII ICACI Final Pr
Page 10 and 11: 8 sneezing runny nose itchy nose it
Page 12 and 13: 10 PRECAUTIONS (continued) ADVERSE
Page 14 and 15: 12 WAO Congress-XVIII ICACI Final P
Page 23 and 24: WAO Congress-XVIII ICACI Final Prog
Page 25 and 26: Whistler alpine resort WAO Congress
Page 29 and 30: XXIII EAACI Congress 12-16 June 200
Page 31 and 32: 7:00 8:00 9:00 10:00 11:00 12:00 13
Page 49 and 50: WEDNESDAY WEDNESDAY SEPTEMBER SEPTE
Page 51 and 52: www.annualmeeting.aaaai.org Visit w
Page 57: WAO Congress-XVIII ICACI Final Prog
Page 61 and 62: FRIDAY, 12 SEPTEMBER WAO Congress-X
Page 63 and 64: Imagine research targeting IgE, a k
Page 98 and 99: 96 PLAN TO ATTEND! SOYEZ DES NÔTRE
Page 100 and 101: 98 Dolovich, Myrna Canada BR86 Dubo
Page 102 and 103: 100 Schnuch, Axel Germany BR88 Scho
Page 104 and 105: 102 201 ACII - Journal of the World
Page 106 and 107: 104 WAO Congress-XVIII ICACI Final
Page 108 and 109:
106 WAO Congress-XVIII ICACI Final
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
114 Crowne Plaza Hotel Georgia 801
Page 118 and 119:
Page 120 and 121:
118 (salmeterol xinafoate/fluticaso
Page 122 and 123:
COPD, the most commonly reported dr
Page 124 and 125:
Page 126 and 127:
124 Seaplane landing at sunset Gran
Page 128:
DS2 - Dinner Symposium Monday, 8 Se
show all

scientific program - World Allergy Organization

Create successful ePaper yourself

Delete template?

Save as template?